Amelogenin: Clinical Trials

1 trial of Amelogenin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Amelogenin: new trials by email Literature Review of Amelogenin trials Research Report on Amelogenin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
AMG 162 180 mg (SC) q 12 weeks, IV Bisphosphonate q 4 weeks, AMG 162- 180 mg q 4 weeks - Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer
Phase 2CompletedAmgen1112005-01-012011-01-24

Conditions studied

Multiple Myeloma (1)

Sponsors

Amgen (1)

Results publications

PMID 19237632, PMID 19524963, PMID 23234632, PMID 33270906